Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Ell, I. Cullum, M. Donaghy, D. Lui, P. Jarritt, M. Harrison (1983)
CEREBRAL BLOOD FLOW STUDIES WITH 123IODINE-LABELLED AMINESThe Lancet, 321
P. Ell, J. Deacon, P. Jarritt, N. Brown, E. Williams (1978)
EMISSION COMPUTERISED TOMOGRAPHY A New Diagnostic Imaging TechniqueThe Lancet, 312
A. Burns, M. Philpot, D. Costa, P. Ell, R. Lévy (1989)
The investigation of Alzheimer's disease with single photon emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 52
W. Domschke, F. Tympner, S. Domschke, E. Wünsch, E. Jaeger, L. Demling (1974)
Letter: Secretin snuff.Lancet, 1 7870
L. Pilowsky, Robin Murray, Robert Kerwin, D. Costa, P. Ell, N. Verhoeff (1992)
Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophreniaThe Lancet, 340
P. Ell, I. Cullum, D. Costa, P. Jarritt, J.M.L. Hocknell, D. Lui, R. Jewkes, T. Steiner, D. Nowotnik, R. Pickett, R. Neirinckx (1985)
REGULAR CEREBRAL BLOOD FLOW MAPPING WITH 99mTc-LABELLED COMPOUNDThe Lancet, 326
R. Bressan, K. Erlandsson, H. Jones, R. Mulligan, R. Flanagan, P. Ell, L. Pilowsky (2003)
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.The American journal of psychiatry, 160 8
(1969)
After graduation from Lisbon University in 1969, I became a junior staff member in a biology laboratory attached to a nuclear research reactor just outside Lisbon
Peter Smith, S. Newman, P. Ell, T. Treasure, P. Joseph, A. Schneidau, M. Harrison (1986)
CEREBRAL CONSEQUENCES OF CARDIOPULMONARY BYPASSThe Lancet, 327
[In the UK, the institute of Nuclear Medicine in London has played an important role in the development of radionuclide investigation of brain. This chapter summarises the very early days of blood brain barrier imaging with labelled pertechnetate, and the use of 3" and 5" sodium iodide crystal scanners in the 60’s, with added simple data processing in the 70’s, progress was continuous, with the introduction of SPET, lyphophilic Tc99m labelled tracers for blood flow studies, the emergence of dopamine transporter imaging in patients with presumed Parkinson’s disease, followed by PET/CT and assessment of glucose metabolism with labelled FDG, and finally the UK introduction of PET/MR and the investigation of the dementias, with labelled amyloid.]
Published: Mar 10, 2016
Keywords: Single Photon Emission Tomography; Focal Epilepsy; Brain Blood Flow; Blood Flow Study; Dopamine Transporter Imaging
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.